Steve Stiles | MDedge

Novel agent for obstructive HCM nets functional gains; top-line results

Publish date: May 14, 2020

Mavacamten showed consistent hemodynamic and functional gains in patients with obstructive hypertrophic...

Publish date: May 11, 2020

Younger patients without heart failure “are the kind of patient who you would probably lean very strongly toward for an S-ICD rather than a...

Publish date: April 22, 2020

ST-segment elevation, often a ticket to the cath lab, may not indicate STEMI as reliably as before hospitals...

Publish date: March 28, 2020

The relative risk reduction was modest, but experts say the benefit in absolute terms was remarkable for already well-treated patients.

Publish date: March 3, 2020

Prescribing a calcium-channel blocker to an elderly patient often leads to a loop diuretic scrip within months...

Publish date: January 2, 2020

EACTS-ESC calls for evidence review and development of updated recommendations for left-main disease “as a matter of urgency.”

Publish date: December 11, 2019

Eleven years after the first attempt of the antiarrhythmic agent, the FDA panel voted resoundingly against approval.

Publish date: November 25, 2019

PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.